Adrenal insufficiency is a complication of transsphenoidal surgery (TSS) for pituitary adenoma, and correct identification of patients requiring glucocorticoid replacement is important. Controversy exists over which early postoperative 9 AM cortisol concentration reliably predicts hypothalamic-pituitaryadrenal (HPA) axis reserve, as defined by the insulin tolerance test (ITT).
tion, glucocorticoid replacement should continue in such cases until definitive testing is performed using an ITT.
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Transsphenoidal surgery (TSS) 3 is an effective treatment for pituitary adenomas and offers the potential for cure (1 ) . However, adrenal insufficiency secondary to the disruption of pituitary function is a wellrecognized complication of TSS. Therefore postoperative biochemical evaluation of the integrity of the hypothalamic-pituitary-adrenal (HPA) axis is imperative (2 ) .
A 9 AM serum cortisol measurement is routinely used to assess the integrity of the HPA axis in the early post-TSS period (3 ) . Because only a single blood sample is required, the relative ease with which the test can be performed has made it a popular tool in assessing the integrity of the HPA axis. The insulin tolerance test (ITT) is widely regarded as the gold standard assessment of HPA-axis integrity (4 -6 ) . The ITT is considered highly reliable at detecting adrenal insufficiency, with only rare cases of adrenal insufficiency reported to be associated with a normal response (7 ) . The test relies on potent upregulation of HPA activity and cortisol secretion in the presence of hypoglycemia. However, the physiological stress associated with hypoglycemia during ITT confers a risk of morbidity and mortality and involves significant patient discomfort (8 ) . The use of ITT is also contraindicated in elderly patients and patients with cardiovascular disease or epilepsy (4 ) . In light of its associated risks, performing ITT is not appropriate during the first few postoperative days, and most centers delay the ITT until 4 -6 weeks after TSS (2, 6 ) .
Controversy still exists over the 9 AM serum cortisol value that most reliably predicts an intact HPA axis after TSS. Correct identification of patients who may or may not require glucocorticoid replacement is vital after TSS because a lack of glucocorticoids may be life threatening, but unnecessary exposure to therapy can be harmful. Until definitive testing of the HPA axis is performed, the initial decision to continue glucocorticoid replacement is routinely based on the value of a 9 AM serum cortisol concentration in the early postoperative period (3 ) .
Numerous algorithms have been recommended to ensure that those patients with a normal HPA axis are not unnecessarily treated with glucocorticoids and to select those requiring dynamic testing of HPA axis function. It is widely accepted that patients with a morning serum cortisol concentration Ͻ100 nmol/L in the early post-TSS period should receive a standard maintenance of glucocorticoids, because they are at high risk of secondary adrenal insufficiency (9 -13 ) . Those patients with serum cortisol concentrations of 80 -250 nmol/L are generally considered to be deficient in adrenocorticotrophin and given glucocorticoid replacement until definitive testing of HPA axis is performed (9 -11, 13 ) . In contrast, little consensus exists regarding glucocorticoid management in patients with a 9 AM serum cortisol concentration Ͼ250 nmol/L post-TSS. It has been suggested that it is safe to withhold routine glucocorticoid replacement in those patients with a morning serum cortisol of Ͼ250 nmol/L in the early post-TSS period until provocative testing of the HPA axis is performed (9, 11 ) . Other investigators, however, have recommended that 9 AM serum cortisol thresholds ranging from Ͻ300 to Ͻ500 nmol/L are suggestive of adrenal insufficiency (12) (13) (14) .
At our center, patients with a 9 AM serum cortisol concentration Ͻ300 nmol/L after TSS are assumed to have secondary adrenal insufficiency and are continued on glucocorticoid replacement until dynamic testing of the integrity of the HPA axis is carried out 6 weeks after TSS. The aim of this study was to investigate in patients with pituitary adenoma the correlation between day 5 postoperative 9 AM serum cortisol concentrations and results of week 6 postoperative dynamic HPA assessment with ITT.
Materials and Methods
We reviewed retrospective data from all patients who underwent TSS for a pituitary adenoma followed by a 9 AM serum cortisol determination 5 days after TSS and an ITT 6 weeks later at Charing Cross Hospital, London, UK, during the period 2001-2008. Nine patients were identified as having Cushing syndrome and were excluded. A total of 36 patients completed all aspects of the protocol. Patient characteristics and details of underlying diagnoses are provided in Table 1 .
After TSS all patients received standard glucocorticoid replacement (hydrocortisone 20 mg AM, 10 mg 12 PM, and 10 mg midafternoon). Glucocorticoid replacement was stopped 18 h before measurement of 9 AM serum cortisol 5 days after TSS. Glucocorticoid replacement (hydrocortisone 10 mg AM, 5 mg 12 PM, and 5 mg midafternoon) was continued if the morning cortisol was Ͻ300 nmol/L, but discontinued if Ն300 nmol/L. All patients were readmitted 6 weeks after TSS for an ITT performed using an established protocol (4 -6 ) . Patients fasted overnight then were administered intravenous insulin (0.1-0.15 U/kg) until symptomatic hypoglycemia was achieved. Blood was sampled for serum glucose and cortisol at 0, 30, 60, 90, and 120 min after insulin injection.
Serum cortisol was measured by use of the Immulite 2000 cortisol assay (Siemans Medical Solutions Diagnostics). In our laboratory the functional sensitivity of the cortisol assay used with Siemans reagents was Ͻ27 nmol/L. CVs for the assay were as follows: cortisol 98 nmol/L, 9.2%; cortisol 347 nmol/L, 6.9%; cortisol 925 nmol/L, 5.6%. A peak cortisol of 500 nmol/L during the ITT was considered a sufficient cortisol response to indicate an intact HPA axis (6 ). Diagnostic sensitivity was defined as the number of patients with a day 5 postoperative serum cortisol correctly identifying secondary adrenal insufficiency, divided by the total number of patients with secondary adrenal insufficiency. Diagnostic specificity was defined as the number of patients with a day 5 postoperative serum cortisol correctly excluding adrenal insufficiency, divided by the total number of patients with adequate adrenal reserve. Positive predictive value (PPV) was defined as the number of patients with a day 5 postoperative serum cortisol correctly identifying adrenal insufficiency, divided by the total number of patients with a day 5 postoperative serum cortisol indicating adrenal insufficiency, whether correctly or not. We calculated 95% CIs for specificity, sensitivity, and PPV.
Results
After TSS, 9 AM serum cortisol concentrations ranged from 27-607 nmol/L, and peak cortisol concentrations during ITT 6 weeks after TSS ranged from 27-971 nmol/L. A total of 23 patients failed the ITT (peak serum cortisol Ͻ500 nmol/L) and had 9 AM post-TSS serum cortisol concentrations ranging from 30 -392 nmol/L. Twenty of these patients had a post-TSS 9 AM serum cortisol concentration suggesting secondary adrenal insufficiency according to a 9 AM serum cortisol cutoff value of 300 nmol/L. However, the remaining 3 patients who failed their ITT had post-TSS 9 AM serum cortisol concentrations of Ͼ300 nmol/L, (322, 353, and 392 nmol/L, Fig. 1 ).
Thirteen patients passed the ITT (peak serum cortisol Ͼ500 nmol/L) and had post-TSS 9 AM serum cortisol concentrations ranging from 111-607 nmol/L. Nine of these patients had a post-TSS 9 AM serum cortisol concentration Ͼ300 nmol/L, suggestive of an intact HPA axis. The remaining 4 patients demonstrated a post-TSS 9 AM serum cortisol Ͻ300 nmol/L (111, 123, 224, and 245 nmol/L) suggestive of secondary adrenal insufficiency but passed their ITT 6 weeks after TSS (Fig. 1) .
Overall, 29 patients had a post-TSS 9 AM serum cortisol concentration that accurately predicted the in- tegrity of the HPA axis when this was assessed by use of an ITT 6 weeks after TSS. A total of 7 patients had a 9 AM serum cortisol concentration that did not correlate with their response during an ITT.
The diagnostic sensitivity, specificity, and PPV for individual post-TSS 9 AM serum cortisol concentrations to predict the integrity of the HPA axis based on the results of an ITT 6 weeks after TSS are shown in Table 2 . The use of a post-TSS 9 AM serum cortisol concentration of Ͻ300 nmol/L to diagnose secondary adrenal insufficiency led to a sensitivity of 86.9% (95% CI 66.4%-97.2%) and a specificity of 69.2% (95% CI 38.6%-90.9%) with a PPV of 83.3% (61.8%-94.5%). The highest post-TSS 9 AM serum cortisol concentration observed in the subgroup that failed the ITT was 392 nmol/L. Increasing the post-TSS 9 AM serum cortisol cutoff to 392 nmol/L to diagnose secondary adrenal insufficiency resulted in 100% (85.2%-100%) sensitivity, and a PPV of 76.6% (57.3%-89.4%), but compromised the specificity (46.1%, 19.2%-74.9%). The lowest post-TSS 9 AM serum cortisol concentration in the subgroup that passed the ITT was 111 nmol/L. Although a reduction in the post-TSS 9 AM serum cortisol cutoff to 111 nmol/L resulted in 100% (75.3%-100%) specificity and 100% (67.9%-100%) PPV; the sensitivity was only 47.8% (26.8%-69.4%). An ROC analysis of the detection of adrenal insufficiency by post-TSS cortisol measurement revealed an area under the curve of 0.84 (95% CI 0.72-0.97) (Fig. 2) .
Discussion
Debate is ongoing regarding which post-TSS 9 AM cortisol concentration ensures that patients with secondary adrenal insufficiency are not misdiagnosed. Watts et al. used a 3-4-day post-TSS 9 AM cortisol concentration of Ͼ250 nmol/L to permit safe withdrawal of replacement glucocorticoids pending further HPA assessment (11 ) . Furthermore, Auchus et al. suggested that a 9 AM cortisol 3 days after TSS of Ͼ250 nmol/L was highly predictive of a normal response to a subsequent ITT (9 ) . In our study, lowering the post-TSS 9 AM cortisol cutoff concentration to 250 nmol/L would have missed 7 of 36 (19.4%) of patients later shown to have secondary adrenal insufficiency as defined by ITT. Hagg et al. proposed that a 9 AM cortisol concentration Ͼ300nmol/L excluded adrenal insufficiency as assessed by ITT (14 ) . Our data suggest that a post-TSS 9 AM cortisol concentration Ͼ300 nmol/L predicts secondary adrenal insufficiency (diagnostic sensitivity 86.9% and positive predictive value 83.3%) and avoids unnecessary glucocorticoid replacement (69.2% diagnostic specificity) in most but not all cases.
The highest post-TSS 9 AM serum cortisol concentration we observed in patients with subnormal response to ITT was 392 nmol/L. This result is comparable to a report suggesting that a 9 AM cortisol concentration of Ͼ400 nmol/L is highly indicative of a Area under the curve is 0.84 (95% CI 0.72-0.97).
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normal response to subsequent hypoglycemia (13 ) . Many groups have suggested that a post-TSS 9 AM cortisol concentration of Ͻ100 nmol/L accurately predicts adrenocorticotrophin deficiency, thus obviating the need to perform an ITT (11, (13) (14) . Our results show that all patients with a post-TSS 9 AM cortisol concentration of Ͻ111 nmol/L have secondary adrenal insufficiency according to the results of their ITT. We therefore suggest that day 5 post-TSS 9 AM cortisol concentrations Ͻ111 nmol/L accurately predict adrenal insufficiency, and concentrations Ͼ392 nmol/L accurately indicate HPA axis reserve. In our study, post-TSS 9 AM cortisol concentrations between 111-392 nmol/L correlated poorly with the results of the ITT performed 6 weeks after TSS. Pavord et al. found that 14% of patients with a 9 AM cortisol concentrationl between 300 -399 nmol/L had a subnormal response during an ITT (13 ) . In comparison, 3 (43%) of the 7 patients in our study with cortisol concentrations between 300 -399 nmol/L showed a subnormal response to ITT. We therefore recommend that patients with day 5 post-TSS 9 AM cortisol concentrations between 111-392 nmol/L should be treated with maintenance glucocorticoid treatment and undergo dynamic testing 6 weeks postoperatively. It has been argued that the use of an even higher day 5 morning cortisol threshold of 450 -500 nmol/L would avoid missing any cases of adrenal insufficiency (11, 13 ) . A disadvantage of this approach, however, is the increased probability of unnecessary treatment with glucocorticoids.
It is interesting to consider what factors may have contributed to the disagreement in the literature regarding detection of adrenal insufficiency by a post-TSS serum cortisol measurement. It is difficult to comment on whether the day of serum sampling affects this relationship, because all studies to date have measured serum cortisol between postoperative days 3 to 7 (9, 10 -11 ) . Although Courtney et al. measured serum cortisol on both 6 and 7 days postoperatively, they did not examine differences between these measurements and those performed 2 days postoperatively (10 ). Our study and previous studies all employed various forms of an immunoassay technique. Assay differences may have therefore contributed to variability in cortisol cutoffs suggested in the literature (9 -13 ) . Additionally, a large fraction of the immunoreactivity detected in these assays is attributable to cortisol metabolites rather than cortisol itself (15 ) . It is therefore important to recognize that more specific assay techniques such as mass spectrometry are likely to have different optimum cortisol cutoffs.
We conclude that a post-TSS 9 AM cortisol concentration of Ͼ392 nmol/L accurately predicts HPA axis integrity, and in these patients glucorticoid therapy can be safely withdrawn, and further definitive testing 6 weeks after TSS is unnecessary. Similarly, a post-TSS 9 AM cortisol concentration of Ͻ111 nmol/L accurately predicts secondary adrenal insufficiency, thus permitting the continuation of glucocorticoid therapy without the need for further testing. However, on day 5 after TSS, 9 AM cortisol concentrations between 111-392 nmol/L are poorly predictive of secondary adrenal insufficiency. In such cases, glucocorticoid replacement should be continued until dynamic testing with ITT can be safely performed.
